Pharmacologic Characteristics of Indinavir, Didanosine, and Stavudine in Human Immunodeficiency Virus-Infected Children Receiving Combination Therapy

The use of human immunodeficiency virus (HIV) protease inhibitors in children has lagged behind that in adults because of the lack of suitable pediatric formulations and information on safe and effective dosing regimens. This study was designed to obtain pharmacokinetic information on indinavir, adm...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Fletcher, Courtney V., Brundage, Richard C., Remmel, Rory P., Page, Linda M., Weller, Dennis, Calles, Nancy R., Simon, Cara, Kline, Mark W.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2000
Soggetti:	Pharmacology
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89808/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10722507/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.4.1029-1034.2000
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!